Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $3.18, representing a -3.34% change from its previous close.

Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that ...

The maker of Claude wants the world to keep one option open. The timing is the tell.

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

One of the key challenges of current multi-agent AI systems is that they communicate by generating and sharing text sequences, which introduces latency, drives up token costs, and makes it difficult ...

What’s New Today: AI chip startup Cerebras is planning a huge $5.5 billion IPO as competition in the AI hardware market intensifies. Fast-Track Insights: UK-based Recursive has secured $650 million in ...

Picture this scenario: An Anthropic Skill scanner runs a full analysis of a Skill pulled from ClawHub or skills.sh. Its markdown instructions are clean, and no prompt injection is detected. No shell ...

SkillRL is a framework that enables LLM agents to learn high-level, reusable behavioral patterns from past experiences. While traditional memory-based methods store redundant and noisy raw ...

Good morning, everyone, and thank you for joining us. Since stepping into this role, I've been focused on a singular question: how do we harness the full power of AI to consistently and with urgency ...